Ron Bentsur - 24 May 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
24 May 2023
Net transactions value
+$3,498
Form type
4
Filing time
26 May 2023, 09:29:16 UTC
Previous filing
18 May 2023
Next filing
01 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $3,498 +200 +0.01% $17.49 3,228,849 24 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.